The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: A double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults

Journal of Hypertension

Volumn 21, Issue 10, 2003, Pages 1905-1914

  Sverrisdóttir, Yrsa Bergmann ^a   Elam, Mikael ^a   Caidahl, Kenneth ^a   Söderling, Ann Sofi ^a   Herlitz, Hans ^a   Johannsson, Gudmundur ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood pressure; Growth hormone; Nitric oxide; Sympathetic nerve activity

Indexed keywords

GROWTH HORMONE; NITRATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GROWTH HORMONE DEFICIENCY; HEART BEAT; HUMAN; HYPOPITUITARISM; INCIDENCE; LONG TERM CARE; MALE; MUSCLE BLOOD VESSEL; NERVE CONDUCTION; NERVE EXCITABILITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECORDING; SHORT COURSE THERAPY; SUBSTITUTION THERAPY; SYMPATHETIC NERVE; URINARY EXCRETION;

EID: 0142074211     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200310000-00018     Document Type: Article

References (60)

1. Evans LM, Davies JS, Goodfellow J, Rees JA, Scanlon MF. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency. Clin Endocrinol 1999; 50:457-464.
2. Rosén T, Edén S, Larson G, Wilhelmsen L, Bengtsson BA. Cardiol vascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol 1993; 129:195-200.
3. Rosén T, Bengtsson B-Ȧ. Premature mortality due to cardiovascular diseases in hypopituitarism. Lancet 1990; 336:285-288.
4. Bengtsson GA, Rosén T, Johansson JO, Johannson G, Oscarsson J, Landin-Wilhelmsen K. Cardiovascular risk factors in adults with growth hormone deficiency. Endocrinol Metab 1995; 2:29-35.
5. Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BA. Growth hormone-deficient adults are insulin-resistant. Metabolism 1995; 44:1126-1129.
6. Evans LM, Davies JS, Anderson RA, Ellis GR, Jackson SK, Lewis MJ, et al. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficency. Eur J Endocrinol 2000; 142:245-262.
7. Boger RH, Skamira C, Bode-Boger SM, Brabant G, von zur Muhlen A, Frolich JC. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. J Clin Invest 1996; 98:2706-2713.
8. Caidahl K, Eden S, Bengtsson BA. Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf) 1994; 40:393-400.
9. Sverrisdóttir YB, Elam M, Herlitz H, Bengtsson BA, Johannsson G. Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency. J Clin Endocrinol Metab 1998; 83:1881-1885.
10. Cohn JN, Levine TB, Metha J. Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med 1984; 311:819-823.
11. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334:374-381.
12. Sverrisdóttir YB, Rundqvist B, Johannsson G, Elam M. Sympathetic neural burst amplitude distribution. A more specific indicator of sympatho-excitation in human heart failure. Circulation 2000; 102: 2076-2081.
13. Ng AV, Callister R, Johnson DG, Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 1993; 21:498-503.
14. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, et al. Effects of sex and age on 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987; 64:51-58.
15. Sundlöf G, Wallin BG. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol 1978; 274:621-637.
16. Flinkenstein JW, Roffwarg HP, Boyar RM, Kream J, Hellman L. Age-related change in the twenty-four-hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab 1972; 35:665-670.
17. 7 Andersson B, Elam M, Wallin BG, Björntorp P, Andersson OK. Effect of energy-restricted diet on sympathetic muscle nerve activity in obese women. Hypertension 1991; 18:783-789.
18. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991; 73:1081-1088.
19. Sverrisdóttir YB, Johannsson G, Jungersten L, Wallin BG, Elam M. Is the somatotropic axis related to sympathetic nerve activity in aging healthy men? J Hypertens 2001; 19:2019-2024.
20. Gudivaka R, Schoeller DA, Kushner RF, Bolt MJ. Single- and multi-frequency models for bioelectrical impedance analysis of body water compartments. J Appl Physiol 1999; 87:1087-1096.
21. Vallbo ÅB, Hagbarth KE, Torebjörk HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 1979; 59:919-957.
22. Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension 1989; 13:647-655.
23. Imholz BPM, Settels JJ, Van Der Meiracker AH, Wesseling KH, Wieling W. Non-invasive continuous finger blood pressure measurement during orthostatic stress compared to intra-arterial pressure. Cardiovasc Res 1990; 24:214-221.
24. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
25. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37: 7-11.
26. Leeson P, Thorne S, Donald A, Mullen M, Clarkson P, Deanfield J. Non-invasive measurement of endothelial function: effect on brachial artery dilatation of graded endothelial dependent and independent stimuli. Heart 1997; 78:22-27.
27. Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 1991; 11:565-577.
28. Ringqvist A, Caidahl K, Petersson AS, Wennmalm A. Diurnal variation of flow-mediated vasodilation in healthy premenopausal women. Am J Physiol Heart Circ Physiol 2000; 279:H2720-H2725.
29. Wallin BG, Sundlof G, Eriksson BM, Dominiak P, Grobecker H, Lindblad LE. Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. Acta Physiol Scand 1981; 111:69-73.
30. Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, Jennings G. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol 1992; 453:45-58.
31. Wallin BG, Thompson JM, Jennings GL, Esler MD. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol 1996; 491:881-887.
32. Fagius J, Wallin BG. Long-term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade. Clin Auton Res 1993; 3:201-205.
33. Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrythmias. N Engl J Med 1991; 325:618-624.
34. Du XJ, Cox HS, Dart AM, Esler MD. Sympathetic activation triggers ventricular arrythmias in rat heart with chronic infarction and failure. Cardiovasc Res 1999; 43:919-929.
35. Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sundlöf G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986; 73: 913-919.
36. Ferguson DW, Berg WJ, Sanders JS. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol 1990; 16:1125-1134.
37. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio, et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure [see comments]. Circulation 1995; 92:3206-3211.
38. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G, Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 1997; 95:169-175.
39. Olivari MT, Levine TB, Ring WS, Simon A, Cohn JN. Normalization of sympathetic nervous system function after orthotopic cardiac transplant in man. Circulation 1987; 76:V62-V64.
40. Levine TB, Olivari MT, Cohn JN. Effects of orthotopic heart transplantation on sympathetic control mechanisms in congestive heart failure. Am J Cardiol 1986; 58:1035-1040.
41. Elam M, Casale R, La Rovere MT, Mortara A, Tavazzi L. Is sympathetic neural hyperactivity in chronic heart failure affected by heart transplantation. Eur Heart J 1993; 14:521-525.
42. Rundqvist B, Casale R, Sverrisdottir YB, Friberg P, Mortara A, Elam M. Rapid fall in sympathetic nerve hyperactivity in patients with heart failure after cardiac transplantation. J Card Fail 1997; 3:21-26.
43. Hjalmarson A, Kneider M, Waagstein F. The role of beta-blockers in left ventricular dysfunction and heart failure. Drugs 1997; 54:501-510.
44. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334,:1349-1355.
45. Rundqvist B, Sverrisdóttir YB, Andersson B, Elam M, Eisenhofer G, Waagstein F, Friberg P. Metoprolol reduces sympathetic nerve hyperactivity in patients with heart failure. J Heart Lung Transplant 2001; 20:251-252.
46. Capaldo B, Lembo G, Rendina V, Vigorito C, Guida R, Cuocolo A, et al. Sympathetic deactivation by growth hormone treatment in patients with dilated cardiomyopathy. Eur Heart J 1998; 19:623-627.
47. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. Clin Invest 1993; 92:1730-1735.
48. Jones PP, Davy KP, Alexander S, Seals DR. Age-related increase in muscle sympathetic nerve activity is associated with abdominal adiposity. Am J Physiol Endocrinol Metab 1997; 272:E976-E980.
49. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981; 30:219-225.
50. Scherrer U, Vollenweider P, Randin D, Jéquier E, Nicod P, Tappz L. Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation 1993; 88:388-394.
51. Fowelin J, Attvall S, Lager I, Bengtsson BA. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 1993; 42:1443-1447.
52. Durand D, Martin JB, Brazeau P. Evidence for a role of alfa-adrenergic mechanism in regulation of episodic growth secretion in the rat. Endocrinology 1978; 100:722-728.
53. Weltman A, Pritzlaff CJ, Wideman L, Weltman JY, Blumer JL, Abbott RD, et al. Exercise-dependent growth hormone release is linked to markers of heightened central adrenergic outflow. J Appl Physiol 2000; 89: 629-635.
54. Lambert GW, Thompson JM, Turner AG, Cox HS, Kalff V, Kelly MJ, et al. Cerebral noradrenaline spillover and its relation to muscle sympathetic nervous activity in healthy human subjects. J Auton Nerv Syst 1997; 64:57-64.
55. Leong KS, Mann P, Wallymahmed M, MacFarlane IA, Wilding JP. Abnormal heart rate variability in adults with growth hormone deficiency. Clin Endocrinol 2000; 85:628-633.
56. Leong KS, Mann P, Wallymahmed M, MacFarlane IA, Wilding JP. The influence of growth hormone replacement on heart rate variability in adults with growth hormone deficiency. Clin Endocrinol 2001; 54:819-826.
57. Valcavi R, Gaddi O, Zini M, Iavicoli M, Mellino U, Portioli I. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J Clin Endocrinol Metab 1995; 80: 659-666.
58. Johannsson G, Bengtsson BA, Andersson B, Isgaard J, Caidahl K. Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients. Clin Endocrinol 1996; 45:305-314.
59. Isgaard J, Bergh CH, Caidahl K, Lomsky M, Hjalmarson A, Bengtsson BA. A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur Heart J 1998; 19:1704-1711.
60. Osterziel KJ, Strohm O, Schuler J, Friedrich M, Hanlein D, Willenbrock R, et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998; 351:1233-1237.